Balloon Technique Shows Promise for Improving Circulation During Cardiac Arrest

A small feasibility study suggests that a minimally invasive balloon procedure, REBOA, may improve blood flow to the heart and brain during out-of-hospital cardiac arrest, potentially increasing survival odds that have remained stagnant for decades.

Chicago Metrowire Staff
••Healthcare
Balloon Technique Shows Promise for Improving Circulation During Cardiac Arrest

A minimally invasive technique that uses a balloon to temporarily block the body's largest artery may help improve circulation to the heart and brain during out-of-hospital cardiac arrest, according to preliminary research presented at the American Heart Association's Resuscitation Science Symposium 2026. The findings matter because survival from out-of-hospital cardiac arrest remains stubbornly low—about 1 in 10—and treatment options have not meaningfully advanced in 50 years.

The procedure, called Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA), involves threading a small balloon through an artery in the groin and inflating it in the upper aorta. This temporarily redirects blood away from the lower body and toward the heart and brain. The technique is already used in trauma centers to control life-threatening internal bleeding, but it is not routinely available in emergency medical services in the United Kingdom or the United States.

In the study of 39 adults in England, physician responders from the East Anglian Air Ambulance used REBOA after patients failed to respond to standard advanced cardiac life support, including CPR (cardiopulmonary resuscitation), defibrillation, medications, and intubation. The balloon was successfully placed in 33 of 36 patients, taking about seven minutes from start to finish, with a median time of 51 minutes from cardiac arrest to balloon inflation.

Several key measures of circulation improved during resuscitation. The aortic diastolic blood pressure—the lower number, which is particularly important for restarting the heart—increased 62%, from 26 to 42 mm Hg, and reached a maximum of 58 mm Hg. The average systolic blood pressure, an important determinant of blood flow to the brain, rose 20%, from 76 to 91 mm Hg. Carbon dioxide in exhaled breath, an indicator of effective circulation during CPR, increased 50%. There were no serious adverse effects related to the procedure.

"Taken together, these findings suggest that aortic occlusion was redirecting blood flow towards the heart and brain as intended," said lead author James Price, M.B.B.S., a consultant emergency physician at Cambridge University Hospitals NHS Foundation Trust and consultant lead for research and development with the East Anglian Air Ambulance. "What surprised us most was the size of the physiological response despite the relatively late stage at which REBOA was performed."

Although the study was not designed to assess survival, 8 of 33 patients with confirmed occlusion regained a sustained return of spontaneous circulation, and 2 survived to hospital discharge with good neurological outcome. In a subgroup of five patients with witnessed ventricular fibrillation who received REBOA earlier, four regained spontaneous circulation and two survived with good neurological outcome.

"This study is an important first step, but it is not yet proof that REBOA saves lives," Price said. He noted that larger prospective studies with comparison groups are needed and that future research should explore delivering the procedure earlier, potentially by training advanced paramedics. The findings are considered preliminary until published in a peer-reviewed journal. The American Heart Association provides resources on recovering from a cardiac arrest and encourages the public to join the Nation of Lifesavers by learning CPR. More information about the meeting is available at About Resuscitation Science Symposium 2026, and general heart health information can be found at heart.org and stroke.org.

Blockchain Registration

QR Code for Blockchain Registration